Summary Table: Pancreas / Endocrine-Specific Promoters

Promoter	Target Cell Type	Size (bp)	Origin	Key Characteristics
Insulin (INS)	beta cells	~400 bp – 2.5 kb	Human	Highly specific for insulin-producing beta cells. Often used in glucose-regulated gene therapy.
RIP	beta cells	~400 bp – 700 bp	Rat	Rat Insulin Promoter. One of the most widely used promoters in diabetes research due to its compact size and strong specificity.
Glucagon (GCG)	alpha cells	~1.0 kb – 1.6 kb	Human / Rat	Directs expression to alpha cells. Useful for studying glucagon regulation and cell-type conversion.
Somatostatin (SST)	delta cells	~600 bp	Human / Rat	Specific for delta cells, which regulate the secretion of both insulin and glucagon.
PDX1	Progenitors	~1.0 kb – 2.5 kb	Mouse / Human	Active in early pancreatic development and mature $\beta$ cells. Used for lineage tracing or “reprogramming” cells.

Technical Insights for Pancreatic Vectors

1. The Dominance of RIP (Rat Insulin Promoter)

While the human insulin promoter is available, the RIP (specifically the RIP2 version) is a staple in the field. It is small enough (~400 bp) to fit into almost any AAV or lentiviral vector while maintaining strict $\beta$-cell restriction. It is often used to drive the expression of “protective” genes to prevent $\beta$-cell death in autoimmune models.

2. Glucose-Responsive Regulation

Native insulin promoters like INS and RIP are naturally glucose-responsive. This means that the “strength” of the promoter increases when blood glucose levels are high. Researchers often exploit this to create “smart” insulin delivery systems where the AAV vector only produces the therapeutic protein when the body actually needs it.

3. Delivery Challenges

Targeting the pancreas often requires specific AAV serotypes like AAV8 or AAV6, which show high tropism for the organ when delivered via the pancreatic duct or systemic injection. Pairing these capsids with a RIP or INS promoter ensures that even if some virus leaks into the liver, the transgene remains silent there.

4. PDX1 and Regenerative Medicine

PDX1 is often used in “reprogramming” experiments. By using a PDX1 promoter, scientists can target specific progenitor populations to drive the expression of transcription factors (like Ngn3 or MafA) to turn non-beta cells into functional, insulin-secreting beta-like cells.